Department of Urology, Tangshan Central Hospital, 063000 Tangshan, China.
Shanghai Engineering Research Center of Pharmaceutical Translation, 200231 Shanghai, China.
Comput Math Methods Med. 2021 May 24;2021:5517747. doi: 10.1155/2021/5517747. eCollection 2021.
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell carcinoma. Cancer-associated fibroblasts (CAFs) as the primary components of cancer stroma can affect tumor progression by secreting exosomes, while exosomes are carriers for proteins, nucleic acids, and other agents that responsible for delivery of biological information. Given this, exosomes derived from CAFs are emerging as promising biomarkers in clinical cancer diagnosis. Nevertheless, their role in clear cell renal cell carcinoma (ccRCC) remains poorly understood.
Here, we separated fibroblasts from ccRCC tissue, extracted exosomes, observed their morphology, and detected the expression of exosome marker proteins including Hsp70, CD9, and CD63. In the meantime, we labeled exosomes and performed coculture experiment to verify the delivery of miR-224-5p from CAFs to 769-P cells with exosomes as a carrier, so as to clarify the effect of CAF-derived exosomes on ccRCC cell malignant behaviors, as well as to discuss how miR-224-5p involves in above regulation.
Transmission electron microscopy was firstly applied, and it was noted that the exosomes we isolated were in normal range. Besides, Western blot also confirmed the presence of exosome marker proteins Hsp70, CD9, and CD63. Furthermore, coculture experiments were performed and the CAF-derived exosomes were observed to be able to facilitate the malignant behaviors of ccRCC cells, and the exosomal miR-224-5p could be internalized by ccRCC cells to participate in regulation of cell proliferation, migration, invasion, and apoptosis.
To sum up, miR-224-5p can enter ccRCC cells via CAF-derived exosomes, in turn, promoting the malignant behaviors of ccRCC cells, which indicates that miR-224-5p has the potential severing as a therapeutic target for ccRCC.
透明细胞肾细胞癌(ccRCC)是肾细胞癌中最常见的亚型。癌症相关成纤维细胞(CAFs)作为肿瘤基质的主要成分,可以通过分泌外泌体来影响肿瘤的进展,而外泌体是负责传递生物信息的蛋白质、核酸和其他物质的载体。鉴于此,源自 CAFs 的外泌体作为有前途的临床癌症诊断生物标志物而出现。然而,它们在透明细胞肾细胞癌(ccRCC)中的作用仍知之甚少。
在这里,我们从 ccRCC 组织中分离出成纤维细胞,提取外泌体,观察其形态,并检测外泌体标记蛋白 Hsp70、CD9 和 CD63 的表达。同时,我们对 exosomes 进行标记并进行共培养实验,以验证 CAFs 来源的 exosomes 以 exosomes 为载体将 miR-224-5p 递送至 769-P 细胞,从而阐明 CAF 衍生的 exosomes 对 ccRCC 细胞恶性行为的影响,并讨论 miR-224-5p 如何参与上述调节。
首先应用透射电子显微镜,注意到我们分离的外泌体在正常范围内。此外,Western blot 还证实了外泌体标记蛋白 Hsp70、CD9 和 CD63 的存在。此外,进行共培养实验并观察到 CAF 衍生的 exosomes 能够促进 ccRCC 细胞的恶性行为,并且 ccRCC 细胞能够内化 exosomal miR-224-5p 参与细胞增殖、迁移、侵袭和凋亡的调节。
综上所述,miR-224-5p 可以通过 CAF 衍生的 exosomes 进入 ccRCC 细胞,进而促进 ccRCC 细胞的恶性行为,这表明 miR-224-5p 具有作为 ccRCC 治疗靶点的潜力。